Top of page

Deanna L. Kirkpatrick


Davis Polk Senior Leadership Team member and the firm’s Finance Partner. Two-time Euromoney “Capital Markets Lawyer of the Year” and a New York Law Journal “Dealmaker.”

Deanna is a member of Davis Polk’s four-person Senior Leadership Team and our Finance Partner, responsible for overseeing the firm’s finances.

Chambers says she is “a great choice of counsel for complex debt and equity transactions, with an excellent track record in biotechnology IPOs,” and it quotes clients who appreciate that “she can command a room or any phone call she is on.” Deanna was named “Debt Capital Markets Lawyer of the Year” at the 2023 Euromoney Women in Business Law Americas Awards, after being recognized for her equity capital markets work two years earlier. She was named a 2021 “Dealmaker of the Year” by New York Law Journal.

Deanna’s practice includes IPOs and other equity, equity-linked debt and other securities offerings, spanning industries including healthcare, retail, financial institutions, utilities, oil and gas, and media. 

Besides advising issuers, she represents major investment banks as underwriters’ counsel and advises clients on securities-law matters.

Experience highlights

Biotech and Life Sciences IPOs
  • SOPHiA GENETICS, GH Research, Cyteir Therapeutics, Molecular Partners, Akoya Biosciences, LAVA Therapeutics, Prometheus Biosciences, Inventiva, Generation Bio, ADC Therapeutics, Ayala Pharmaceuticals, Beam Therapeutics, Progyny, Innate Pharma S.A., BioNTech SE, Stoke Therapeutics, Orchard Therapeutics plc, Aptinyx Inc., Magenta Therapeutics, Inc., Solid Biosciences Inc., InflaRx N.V., Kala Pharmaceuticals, Inc., Dova Pharmaceuticals, Inc., Jounce Therapeutics, Inc., Patheon N.V., Cynapsus Therapeutics Inc. and Oxford Immunotec.
Consumer Retail Work
  • IPOs for companies including ON Running and Krispy Kreme. Advice to VF on its spinoff of Kontoor Brands. Multiple types of stock and bond offerings for companies including Kontoor Brands, VF and Shake Shack.
  • Decarbonization Plus Acquisition Corp. II and III, Disruptive Acquisition Corporation I, Virgin Group Acquisition Corp. II, Kadem Sustainable Impact Corp., Silver Spike Acquisition Corp. II, Frontier Acquisition Corp., PWP Forward Acquisition Corp. I, Aurora Acquisition Corp., Anzu Special Acquisition Corp. I, Freedom Acquisition I Corp., Austerlitz Acquisition Corporation I and II, Soaring Eagle Acquisition Corp., Figure Acquisition Corp. I, Tuatara Capital Acquisition Corporation, Priveterra Acquisition Corp., Thimble Point Acquisition Corp., CC Neuberger Principal Holdings III, Climate Real Impact Solutions II, Science Strategic Acquisition Corp. and Primavera Capital Acquisition Corp. among many more.
Other Work
  • She has also participated in securities offerings by Fortune 500 companies such as Abbott, DXC, Hess and Lockheed Martin.
  • Deanna has also represented virtually all the major investment banks, including JPMorgan Chase, Citi, Goldman Sachs and Morgan Stanley as underwriters’ counsel in equity and debt offerings and regularly advises investment banking clients on securities law-related matters.
View more experience


SEC adopts final SPAC rules



Euromoney Women in Business Law Americas Awards – “Debt Capital Markets Lawyer of the Year,” 2023

Euromoney Women in Business Law Americas Awards – “Equity Capital Markets Lawyer of the Year,” 2021

New York Law Journal – “Dealmaker of the Year,” 2021

IFLR1000 – Women Leaders: United States, 2022

Chambers USA – Capital Markets: Debt & Equity: Eastern United States

Chambers Global – Capital Markets: Debt & Equity: Eastern United States

Chambers USA – SPACs

IFLR1000 – Capital Markets: Debt, United States, Highly Regarded

New York Law Journal – “Distinguished Leader,” 2017

Law360 – “Capital Markets MVP,” 2016

Euromoney Women in Business Law Americas Awards – “Best in Capital Markets,” 2013

M.B.A./LL.B., University of Western Ontario
B.A., Queen's University
Professional history
  • Davis Polk since 1989
  • Senior Leadership Team, 2019-present
Qualifications and admissions
  • State of New York
Back to top